This page is for patients who are considering eye surgery and want to understand why some enquiries are not proceeded with, and what that decision tells them about the clinic.
A Surgeon Who Declines Patients Is a Surgeon Applying Clinical Criteria
Approximately 12-18% of elective refractive surgery enquiries at Blue Fin Vision® do not result in surgery. The reasons are clinical, not commercial. Corneal thickness below the safe threshold for laser correction, active ocular surface disease, unstable refraction, pre-existing macular pathology, insufficient accommodation for a specific lens strategy, or expectations incompatible with the achievable result. In each case, the clinical pathway is either a different procedure, a delay while a reversible condition is treated, or a recommendation not to proceed with elective surgery at all.
A provider that never declines a patient is a provider whose selection criteria are commercial rather than clinical. This is a meaningful signal. Private eye surgery is elective, and elective surgery in a patient who is not an appropriate candidate is a decision about revenue, not about outcomes.
Common Reasons Patients Are Declined or Redirected
- Thin cornea: laser correction not safe; ICL recommended instead.
- Active dry eye: surface must be optimised before any intraocular or laser procedure.
- Keratoconus or forme fruste keratoconus: laser correction contraindicated; corneal cross-linking or ICL assessed.
- High myopia with long axial length: RLE carries higher retinal detachment risk; ICL preferred.
- Macular pathology (AMD, diabetic maculopathy, epiretinal membrane): trifocal IOL outcomes reduced; monofocal or observation advised.
- Unrealistic expectations: trifocal IOL or premium refractive surgery not offered if the patient’s expectation cannot be matched by the procedure.
- Pre-operative refraction unstable: surgery deferred until stability is confirmed over at least six weeks.
What This Means for the Patient
A decline is not a dismissal. It is a clinical statement that the proposed procedure is not the right one for this patient, or not yet. The follow-up is either a different procedure, a period of treatment, or a recommendation to remain in optical correction. At Blue Fin Vision®, every declined patient receives a written summary of the reasoning and, where applicable, the alternative pathway.
Clinical Perspective
At Blue Fin Vision®, Mr Mfazo Hove and the clinical team decline approximately 12-18% of refractive surgery enquiries annually. This is consistent with the published literature on appropriate selection and is a figure that a patient can use as a quality indicator when comparing providers. A clinic that cannot tell you what proportion of enquiries it declines, or that appears to proceed with every patient, is describing a different operating model. This is often not disclosed at volume laser providers, where the commercial pathway is designed to convert rather than to select.
Clinical Takeaway
A surgeon who declines patients is applying clinical criteria, not restrictive practice. Approximately 12-18% of refractive enquiries at Blue Fin Vision® are declined or redirected. The reasons are specific, documented, and communicated in writing. If you are researching providers, ask what percentage of patients they decline, the answer tells you how clinical their selection process is.
References
- Randleman JB, Russell B, Ward MA, Thompson KP, Stulting RD. Risk factors and prognosis for corneal ectasia after LASIK. Ophthalmology. 2003;110(2):267-75.
- Ambrosio R Jr, Klyce SD, Wilson SE. Corneal topographic and pachymetric screening of keratorefractive patients. J Refract Surg. 2003;19(1):24-9.
- Alio JL, Grzybowski A, El Aswad A, Romaniuk D. Refractive lens exchange. Surv Ophthalmol. 2014;59(6):579-98.
- Shtein RM. Post-LASIK dry eye. Expert Rev Ophthalmol. 2011;6(5):575-82.
- Sanders DR, Vukich JA. Comparison of implantable contact lens and laser assisted in situ keratomileusis for moderate to high myopia. Cornea. 2003;22(4):324-31.
